ESH/LinkedIn
Mar 3, 2026, 15:16
Transplant vs CAR T Cells in Multiple Myeloma Debate at ESHMM 2026 – ESH
European School of Haematology (ESH) shared a post on LinkedIn:
“Programme Highlight of ESHMM 2026!
Debate 3 – Transplant vs CAR T cells.
Moderated by Martin Kaiser with Mohamad Mohty and Robert Orlowski (with audience voting)
Less than a month to go before the conference begins!
Secure your spot today — Register now and Join us on March 26-28, 2026 in Stockholm, Sweden.
8th Translational Research Conference on Multiple Myeloma.
Conference Chairs: Hartmut Goldschmidt, Martin Kaiser, Suzanne Lentzsch”
Stay updated with Hemostasis Today.
-
Mar 3, 2026, 15:34Tareq Abadl: Why Is Measuring Schistocytes Critical in a Thrombocytopenic Patient?
-
Mar 3, 2026, 15:32Sanna Rijpma: The Evaluation of The Thrombin Generation Capacity in Detecting Coagulation Factor Deficiency
-
Mar 3, 2026, 15:28Mary Cushman Elected ISTH President for 2028–2030
-
Mar 3, 2026, 15:20Brian A Beh: 5 Strategies to Assist and Maintain Motivation During Stroke Rehabilitation
-
Mar 3, 2026, 15:07Nancy Di Salvo: Turning Challenges Into Purpose and Making Every Voice Count on Rare Disease Day 2026
-
Mar 3, 2026, 15:01Wolfgang Miesbach: How Laboratory Strategies Must Evolve to Meet Expanding Haemophilia Therapies
-
Mar 3, 2026, 14:46Jessica Nolan: Exploring Religious Coping in Stroke Survivors
-
Mar 3, 2026, 14:45Research Isn’t Abstract Science But a Pathway to Answers, Treatments, and Hope – ASH
-
Mar 3, 2026, 14:42Mervyn Morgan: Attending the Rare Haematology and Blood Disorders Cohort Meeting